News | Structural Heart | March 25, 2024

CLS Health Cardiologists Achieve Historic First with Transcarotid TAVR in Southeast Houston

The cutting-edge procedure that avoids open-heart surgery is momentous in cardiac care

The cutting-edge procedure that avoids open-heart surgery is momentous in cardiac care

March 25, 2024 — In a groundbreaking medical advancement, three esteemed cardiologists from CLS Health, Dr. Bahaeddin Shabaneh, Dr. Fethi Benraouane, and Dr. Molham Aldeiri, have successfully performed the first series of transcarotid Transcatheter Aortic Valve Replacement (TAVR) procedures ever done in Southeast Houston. This innovative approach, which involves replacing a diseased aortic valve through a small neck incision without the need for open-heart surgery, marks a significant leap forward in cardiac care. 

TAVR, whether through the groin approach or neck approach, only requires a half-inch or inch incision. It is increasingly overtaking surgical valve replacement through open heart surgery in patients 65 years or older, as it may achieve comparable results without opening the patient's chest. 

The TAVR surgery is a minimally invasive technique performed under local anesthesia with sedation that provides hope for patients who are ineligible for the conventional femoral artery approach. The unique aspect of the carotid approach is done by making a small incision in the neck to deliver the aortic valve in patients who cannot have it through the femoral artery in the groin, which is the standard approach. This novel approach potentially decreases the risk of stroke and vascular complications and makes more options available for patients. 

CLS Health cardiologists Dr. Bahaeddin Shabaneh, Dr. Fethi Benraouane, Dr. Molham Aldeiri, and Dr. Ahmad Al-Taweel collectively have performed the highest number of TAVR procedures in Southeast Houston, and a sizable portion of the 600+ procedures done at hospitals in the area (HCA Houston Healthcare Clear Lake, Memorial Herman Southeast), compared to other cardiologists and groups in the area.  

CLS Health is committed to delivering exemplary care through innovative procedures, ensuring patients in Southeast Houston and beyond have access to the best possible cardiac treatments. 

For more information: https://cls.health/

 


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now